OnKure Therapeutics, Inc. — All Filings
345 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001692747-26-000001 | Mar 24, 2026 | Mar 23, 2026 |
| 4 | — | 0001609284-26-000001 | Mar 24, 2026 | Mar 23, 2026 |
| S-8 | S-8 | 0001193125-26-104215 | Mar 12, 2026 | — |
| 10-K | 10-K | 0001193125-26-104147 | Mar 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-104104 | Mar 12, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016541 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-016660 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001088 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000240 | Jan 30, 2026 | — |
| 4 | 4 | 0001193125-26-000942 | Jan 2, 2026 | Dec 31, 2025 |
| 4 | — | 0001622769-26-000001 | Jan 2, 2026 | Dec 31, 2025 |
| 4 | — | 0001609284-25-000004 | Dec 23, 2025 | Dec 22, 2025 |
| 4 | — | 0001692747-25-000004 | Dec 23, 2025 | Dec 22, 2025 |
| SCHEDULE 13G | — | 0001104659-25-116660 | Nov 28, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-291362 | Nov 21, 2025 | — |
| EFFECT | — | 9999999995-25-003308 | Nov 18, 2025 | — |
| 8-K | 8-K | 0001193125-25-269468 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-269652 | Nov 6, 2025 | — |
| S-3 | S-3 | 0001193125-25-270073 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269540 | Nov 6, 2025 | Sep 30, 2025 |
| POS AM | POS AM | 0001193125-25-270150 | Nov 6, 2025 | — |
| 424B3 | 424B3 | 0001193125-25-269724 | Nov 6, 2025 | — |
| 4 | — | 0001622769-25-000003 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | 4 | 0001193125-25-228402 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | — | 0001609284-25-000003 | Sep 24, 2025 | Sep 22, 2025 |
| 4 | — | 0001692747-25-000003 | Sep 24, 2025 | Sep 22, 2025 |
| SCHEDULE 13G | — | 0000902664-25-003640 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-109073 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-021974 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0001213900-25-076638 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-178981 | Aug 12, 2025 | Jun 30, 2025 |
| 424B3 | 424B3 | 0001193125-25-178979 | Aug 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-178978 | Aug 12, 2025 | — |
| 4 | — | 0001415889-25-019052 | Jul 2, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-093063 | Jul 2, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-090403 | Jun 26, 2025 | — |
| 4 | — | 0001415889-25-018235 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-018234 | Jun 25, 2025 | Jun 23, 2025 |
| 4 | — | 0001415889-25-015018 | May 30, 2025 | May 28, 2025 |
| SCHEDULE 13D/A | — | 0001636587-25-000030 | May 30, 2025 | — |
| 4 | — | 0001415889-25-015019 | May 30, 2025 | May 28, 2025 |
| 4 | — | 0001415889-25-015015 | May 30, 2025 | May 28, 2025 |
| 4 | — | 0001415889-25-015016 | May 30, 2025 | May 28, 2025 |
| 4 | 4 | 0000950170-25-079841 | May 30, 2025 | May 28, 2025 |
| 4 | — | 0001415889-25-015014 | May 30, 2025 | May 28, 2025 |
| SCHEDULE 13G | — | 0001723643-25-000011 | May 29, 2025 | — |
| 8-K | 8-K | 0000950170-25-078375 | May 28, 2025 | May 27, 2025 |
| 424B3 | 424B3 | 0000950170-25-078388 | May 28, 2025 | — |
| 3 | 3 | 0000950170-25-078004 | May 27, 2025 | May 15, 2025 |
| SCHEDULE 13D | — | 0001636587-25-000027 | May 22, 2025 | — |